MedPath

ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website
http://www.sj-hospital.org

Clinical Trials

112

Active:6
Completed:26

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:4
Phase 2:16
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (66 trials with phase data)• Click on a phase to view related trials

Not Applicable
33 (50.0%)
Phase 2
16 (24.2%)
Phase 4
9 (13.6%)
Phase 1
4 (6.1%)
Phase 3
3 (4.5%)
Early Phase 1
1 (1.5%)

Near-Infrared Imaging of Motor Imagery Effects in Spinal Cord Injury

Not Applicable
Recruiting
Conditions
SCI - Spinal Cord Injury
Motor Imagery
Brain-Computer Interfaces
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
Shengjing Hospital
Target Recruit Count
36
Registration Number
NCT07106060
Locations
🇨🇳

Rehabilitation Center of Shengjing Hospital, China Medical University, Shenyang, Liaoning, China

A Randomized Study of JS004 and Toripalimab Combined With Chemotherapy vs Toripalimab Combined With Chemotherapy vs Chemotherapy Alone as Neoadjuvant Therapy for Stage II-III Triple-negative Breast Cancer (TNBC).

Not Applicable
Not yet recruiting
Conditions
TNBC - Triple-Negative Breast Cancer
Interventions
Drug: JS004 in combination with toripalimab and chemotherapy
Drug: Toripalimab and chemotherapy
Drug: Chemotherapy
First Posted Date
2025-08-03
Last Posted Date
2025-08-03
Lead Sponsor
Shengjing Hospital
Target Recruit Count
125
Registration Number
NCT07101614

Effect of Threshold Pressure-Loaded RMT + tTBS on Respiratory Function in SCI Patients

Not Applicable
Recruiting
Conditions
Spinal Cord Injuries
First Posted Date
2025-07-03
Last Posted Date
2025-07-03
Lead Sponsor
Shengjing Hospital
Target Recruit Count
60
Registration Number
NCT07050069
Locations
🇨🇳

Rehabilitation Center of Shengjing Hospital, China Medical University, Shenyang, Liaoning, China

Study on Dynamic Changes of Serum IGF-1 Post-Cerebral Hemorrhage and Its Prognostic Correlation

Not yet recruiting
Conditions
Insulin-Like Growth Factor I
First Posted Date
2025-06-29
Last Posted Date
2025-06-29
Lead Sponsor
Shengjing Hospital
Target Recruit Count
100
Registration Number
NCT07043504

fNIRS-Driven Visual Feedback Training to Restore Walking After Stroke

Not Applicable
Recruiting
Conditions
Stroke
First Posted Date
2025-06-11
Last Posted Date
2025-06-24
Lead Sponsor
Shengjing Hospital
Target Recruit Count
44
Registration Number
NCT07014891
Locations
🇨🇳

Rehabilitation Center of Shengjing Hospital, China Medical University, Shenyang, Liaoning, China

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.